전자약(Electroceuticals) 시장 : 제품별, 종류별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Electroceuticals Market size was valued at USD 22,456.45 Million in 2024, expanding at a CAGR of 7.60% from 2024 to 2032.

Electroceuticals, also known as bioelectronic medicines, are a class of therapeutic devices that use electrical impulses to modulate the body's neural circuits, offering an alternative or complement to pharmaceutical treatments. These devices target specific nerves or brain regions to treat various medical conditions, including chronic pain, epilepsy, Parkinson's disease, depression, and even inflammatory disorders. Unlike traditional pharmaceuticals that rely on chemical interactions within the body, electroceuticals operate by influencing the electrical signaling pathways that underlie physiological processes. Typically, electroceutical devices are either implanted or wearable, depending on the condition being treated. For example, deep brain stimulators, vagus nerve stimulators, and spinal cord stimulators are commonly used implantable electroceuticals. These devices deliver precisely controlled electrical signals to alter abnormal nerve activity, helping to restore normal function or alleviate symptoms. Recent advancements in neuroscience, bioengineering, and miniaturization have driven innovation in this field, enabling more targeted and less invasive treatments. Electroceuticals are considered promising in areas where conventional drug therapies may fall short due to side effects, limited efficacy, or resistance. By harnessing the body's electrical system, electroceuticals open up new possibilities for personalized and precise medical interventions, potentially transforming the way chronic diseases are managed in the future.

Electroceuticals Market- Market Dynamics

Rising Prevalence of Neurological Disorders Driving Demand

The increasing incidence of neurological disorders is significantly contributing to the growth of the electroceuticals market. Conditions such as Parkinson's disease, epilepsy, chronic depression, Alzheimer's disease, and multiple sclerosis are becoming more prevalent due to factors like aging populations, lifestyle changes, and improved diagnostic capabilities. These disorders often have limited treatment options, and conventional pharmaceutical approaches may lead to inadequate results or undesirable side effects. As a result, there is a growing shift toward advanced therapeutic solutions that offer greater precision and fewer systemic impacts. Electroceuticals provide a novel approach by directly targeting neural circuits responsible for disease symptoms through electrical stimulation. Technologies such as deep brain stimulation (DBS), vagus nerve stimulation (VNS), and spinal cord stimulation (SCS) have shown considerable success in managing complex neurological conditions. With better outcomes in symptom control and patient quality of life, these devices are gaining traction among healthcare providers and patients alike.

ELECTROCEUTICALS Market- Key Insights

According to our research analyst, the global Electroceuticals Market is expected to develop at a CAGR of approximately 7.60% between 2024-2032.

Segmented by Product in 2023, the Cardiac Pacemakers & Implantable Cardioverter Defibrillators category dominated the market.

Based on type, the Implantable Electroceutical Devices generated the most income in 2023.

Based on region, in 2023, North America was the region with the highest revenue.

Electroceuticals Market- Segmentation Analysis:

The global Electroceuticals market is divided into three categories: product, type, application and region.

The electroceuticals market is segmented by product into Cardiac Pacemakers & Implantable Cardioverter Defibrillators (ICDs), Cochlear Implants, Neuromodulators, and Retinal Implants. Among these, Cardiac Pacemakers & ICDs are expected to dominate the market. This dominance is primarily driven by the high global prevalence of cardiovascular diseases, including arrhythmias and heart failure, which require timely intervention through electrical stimulation of the heart. These devices are widely adopted due to their proven efficacy, technological advancements, and increasing use in aging populations who are more susceptible to heart conditions. Additionally, the availability of reimbursement policies in developed countries and ongoing innovation in minimally invasive cardiac devices further boost their adoption. While cochlear implants and neuromodulators are growing segments, the long-standing clinical use, robust infrastructure, and life-saving potential of cardiac devices secure their leading position in the market. As cardiovascular diseases remain a leading cause of mortality worldwide, demand for these devices is expected to remain strong.

By type electroceuticals market is segmented into Implantable Electroceutical Devices and Noninvasive Electroceutical Devices. Among these, Implantable Electroceutical Devices hold the dominant share of the market. This dominance is attributed to their widespread application in treating critical, chronic conditions such as cardiac arrhythmias, epilepsy, and Parkinson's disease. Devices like cardiac pacemakers, implantable cardioverter defibrillators (ICDs), deep brain stimulators, and vagus nerve stimulators offer targeted therapy with high efficacy and long-term benefits, making them the preferred choice for severe medical conditions. Implantable devices also benefit from continuous advancements in miniaturization, battery technology, and device programming, which enhance their safety and performance. Furthermore, their long-standing clinical acceptance and robust reimbursement frameworks in developed markets support broader adoption. Although noninvasive devices are gaining traction for mild conditions and home-based therapies, implantable electroceuticals continue to lead the market due to their therapeutic precision and life-saving applications.

Electroceuticals Market- Geographical Insights

Geographically, the Electroceuticals Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America holds the largest share of the global electroceuticals market, with the United States as the primary contributor. The region benefits from a robust healthcare infrastructure, high healthcare spending, and rapid adoption of advanced medical technologies. A rising prevalence of chronic disorders-such as Parkinson's disease, epilepsy, cardiovascular conditions, and hearing loss-drives consistent demand for implantable devices like cardiac pacemakers, ICDs, cochlear implants, and deep brain stimulators. Additionally, the presence of key market players such as Medtronic, Abbott, and Boston Scientific ensures strong research, development, and commercialization pipelines. Regulatory agencies such as the U.S. FDA provide a well-defined framework for medical device approvals, promoting innovation and market entry. Moreover, favorable reimbursement policies and growing physician and patient awareness further support market expansion. The U.S. also leads in clinical trials and academic research focused on neuromodulation and bioelectronic medicine. Canada, while smaller in market size, also contributes through public healthcare initiatives and increased access to advanced treatments. As the region continues to invest in personalized medicine, digital health integration, and miniaturized bioelectronic devices, North America is expected to maintain its leadership in the electroceuticals landscape over the coming years.

Europe stands as the second-largest market for electroceuticals, driven by an aging population and a rising incidence of neurological and cardiovascular disorders. Countries such as Germany, the United Kingdom, and France are major revenue generators due to their advanced healthcare infrastructure, comprehensive insurance coverage, and proactive regulatory support. The region has shown a strong inclination toward adopting innovative therapeutic technologies, including deep brain stimulation, vagus nerve stimulation, and cochlear implants. Europe is home to prominent academic institutions and research centers contributing to bioelectronic medicine development. Funding from both public health bodies and the European Union fosters the growth of clinical research and device innovation. Furthermore, high patient awareness and clinician expertise in neuromodulation therapies bolster adoption rates. Reimbursement frameworks in many European countries support access to high-cost medical technologies, thereby increasing patient uptake of electroceutical treatments.

Electroceuticals Market- Competitive Landscape:

The electroceuticals market is highly competitive, with dominance from established medical device manufacturers such as Medtronic, Boston Scientific Corporation, and Abbott, who leverage extensive R&D capabilities, regulatory expertise, and global distribution networks. These companies focus on expanding their portfolios through innovative solutions in cardiac devices, neuromodulation, and hearing implants. LivaNova Plc, Cochlear Ltd., and Sonova specialize in niche segments like vagus nerve stimulation and cochlear implants, enhancing patient outcomes in neurological and auditory disorders. Meanwhile, emerging players such as Axonics Inc., Neuronetics, ElectroCore Inc., and NeuroPace Inc. are driving innovation through minimally invasive and wearable neuromodulation technologies targeting conditions like depression, epilepsy, and overactive bladder. MicroPort Scientific Corporation and Nervo Corp. are expanding their footprint in Asia and North America, respectively. This competitive landscape, characterized by strategic acquisitions, partnerships, and continuous product development, fosters a dynamic environment that promotes technology advancement and broader adoption of electroceutical therapies worldwide.

Recent Developments:

In April 2024, Axonics Inc. announced FDA approval for its next-generation rechargeable sacral neuromodulation system, offering longer battery life and improved patient comfort.

In January 2024, Boston Scientific Corporation acquired Relievant Medsystems, a company specializing in intraosseous basivertebral nerve ablation therapy, to expand its chronic pain management portfolio.

In November 2023, Abbott received CE Mark approval for its Eterna(TM) spinal cord stimulation system, featuring its smallest implantable rechargeable neurostimulator designed for chronic pain relief.

In September 2023, Neuronetics launched the NeuroStar Advanced Therapy System in new markets across Europe, expanding access to transcranial magnetic stimulation (TMS) for major depressive disorder.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ELECTROCEUTICALS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Medtronic
• Boston Scientific Corporation
• Abbott
• Livanova Plc
• Cochlear Ltd.
• Microport Scientific Corporation
• Sonova
• Nervo Corp.
• Axonics Inc.
• Neuronetics
• Electrocore Inc.
• Neuropace Inc.
• Others

GLOBAL ELECTROCEUTICALS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

• Cardiac Pacemakers & Implantable Cardioverter Defibrillators
• Cochlear Implants
• Neuromodulators
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Vagus Nerve Stimulators
• Sacral Nerve Stimulators
• Gastric Electrical Stimulators
• Transcranial Magnetic Stimulators
• Respiratory Electrical Stimulators
• Trigeminal Nerve Stimulators
• Responsive Neurostimulators
• Retinal Implants

GLOBAL ELECTROCEUTICALS MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

• Implantable Electroceutical Devices
• Noninvasive Electroceutical Devices

GLOBAL ELECTROCEUTICALS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Cardiac Pacemakers & Implantable Cardioverter Defibrillators
• Arrhythmia
• Heart Failure
• Other Cardiac Pacemaker & Icd Applications
• Spinal Cord Stimulators
• Chronic Pain
• Failed Back Surgery Syndrome
• Ischemia
• Deep Brain Stimulators
• Parkinson's Disease
• Tremors
• Depression
• Other DBS Applications
• Sacral Nerve Stimulators
• Urine Incontinence
• Fecal Incontinence
• Vagus Nerve Stimulators
• Epilepsy
• Other VNS Applications
• Gastric Electrical Stimulators
• Gastroparesis
• Obesity
• Transcutaneous Electrical Nerve Stimulators
• Treatment-Resistant Depression
• Other TENS Application
• Transcranial Magnetic Stimulators
• Depression
• Migraine
• Respiratory Electrical Stimulators
• Spinal Cord Injury
• Trigeminal Nerve Stimulators
• Attention-Deficit/Hyperactivity Disorder
• Migraine

GLOBAL ELECTROCEUTICALS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Electroceuticals Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Electroceuticals Market Snippet by Product
  • 2.1.2. Electroceuticals Market Snippet by Type
  • 2.1.3. Electroceuticals Market Snippet by Application
  • 2.1.4. Electroceuticals Market Snippet by Country
  • 2.1.5. Electroceuticals Market Snippet by Region
• 2.2. Competitive Insights

3. Electroceuticals Key Market Trends

• 3.1. Electroceuticals Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Electroceuticals Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Electroceuticals Market Opportunities
• 3.4. Electroceuticals Market Future Trends

4. Electroceuticals Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Electroceuticals Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Electroceuticals Market Landscape

• 6.1. Electroceuticals Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Electroceuticals Market - By Product

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
  • 7.1.2. Cardiac Pacemakers & Implantable Cardioverter Defibrillators
  • 7.1.3. Cochlear Implants
  • 7.1.4. Neuromodulators
    • 7.1.4.1. Spinal Cord Stimulators
    • 7.1.4.2. Deep Brain Stimulators
    • 7.1.4.3. Vagus Nerve Stimulators
    • 7.1.4.4. Sacral Nerve Stimulators
    • 7.1.4.5. Gastric Electrical Stimulators
    • 7.1.4.6. Transcranial Magnetic Stimulators
    • 7.1.4.7. Respiratory Electrical Stimulators
    • 7.1.4.8. Trigeminal Nerve Stimulators
    • 7.1.4.9. Responsive Neurostimulators
  • 7.1.5. Retinal Implants

8. Electroceuticals Market - By Type

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
  • 8.1.2. Implantable Electroceutical Devices
  • 8.1.3. Non-invasive Electroceutical Devices

9. Electroceuticals Market - By Application

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 9.1.2. Cardiac Pacemakers & Implantable Cardioverter Defibrillators
    • 9.1.2.1. Arrhythmia
    • 9.1.2.2. Heart Failure
    • 9.1.2.3. Other Cardiac Pacemaker & Icd Applications
  • 9.1.3. Spinal Cord Stimulators
    • 9.1.3.1. Chronic Pain
    • 9.1.3.2. Failed Back Surgery Syndrome
    • 9.1.3.3. Ischemia
  • 9.1.4. Deep Brain Stimulators
    • 9.1.4.1. Parkinson's Disease
    • 9.1.4.2. Tremors
    • 9.1.4.3. Depression
    • 9.1.4.4. Other Dbs Applications
  • 9.1.5. Sacral Nerve Stimulators
    • 9.1.5.1. Urine Incontinence
    • 9.1.5.2. Fecal Incontinence
  • 9.1.6. Vagus Nerve Stimulators,
    • 9.1.6.1. Epilepsy
    • 9.1.6.2. Other Vns Applications
  • 9.1.7. Gastric Electrical Stimulators
    • 9.1.7.1. Gastroparesis
    • 9.1.7.2. Obesity
  • 9.1.8. Transcutaneous Electrical Nerve Stimulators
    • 9.1.8.1. Treatment-Resistant Depression
    • 9.1.8.2. Other Tens Application
  • 9.1.9. Transcranial Magnetic Stimulators
    • 9.1.9.1. Depression
    • 9.1.9.2. Migraine
  • 9.1.10. Respiratory Electrical Stimulators
    • 9.1.10.1. Spinal Cord Injury
  • 9.1.11. Trigeminal Nerve Stimulators
    • 9.1.11.1. Attention-Deficit/Hyperactivity Disorder
    • 9.1.11.2. Migraine

10. Electroceuticals Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Electroceuticals Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Electroceuticals Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.8. France
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.8.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.8.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.9. Italy
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.9.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.10. Spain
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.10.4. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.11. United Kingdom
    • 10.3.11.1. Overview
    • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.11.4. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.11.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.12. Russia
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.12.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.13. Netherlands
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.13.3. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.14. Sweden
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.14.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.15. Poland
    • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.16. Rest of Europe
    • 10.3.16.1. Overview
    • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Electroceuticals Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.9. South Korea
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.9.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.9.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.10. Japan
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.10.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Electroceuticals Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Electroceuticals Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Electroceuticals Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Medtronic
  • 11.2.2. Boston Scientific Corporation
  • 11.2.3. Abbott
  • 11.2.4. Livanova Plc
  • 11.2.5. Cochlear Ltd.
  • 11.2.6. Microport Scientific Corporation
  • 11.2.7. Sonova
  • 11.2.8. Nervo Corp.
  • 11.2.9. Axonics Inc.
  • 11.2.10. Neuronetics
  • 11.2.11. Electrocore Inc.
  • 11.2.12. Neuropace Inc.
  • 11.2.13. Others

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us